| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/29/1997 | WO1997019091A1 Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions |
| 05/29/1997 | WO1997019089A1 Oxazolidinone antibacterial agent with tricyclic substituents |
| 05/29/1997 | WO1997019086A1 Epothilone derivatives, preparation and use |
| 05/29/1997 | WO1997019084A1 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/29/1997 | WO1997019081A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997019075A1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 05/29/1997 | WO1997019074A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 05/29/1997 | WO1997019070A1 Tricyclic spiro compounds as 5ht1d receptor antagonists |
| 05/29/1997 | WO1997019066A1 New quinoxalindione derivatives, their preparation and use in medicaments |
| 05/29/1997 | WO1997019064A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 05/29/1997 | WO1997019063A1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/29/1997 | WO1997019062A1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 05/29/1997 | WO1997019060A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
| 05/29/1997 | WO1997019059A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/29/1997 | WO1997019058A1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols |
| 05/29/1997 | WO1997019055A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/29/1997 | WO1997019054A1 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 05/29/1997 | WO1997019053A1 Metalloproteinase inhibitors |
| 05/29/1997 | WO1997019052A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 05/29/1997 | WO1997019050A1 Synthesis of carboxylic acid derivatives |
| 05/29/1997 | WO1997018839A1 Solid mixtures of cyclodextrins prepared via melt-extrusion |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018835A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 05/29/1997 | WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | WO1997018824A1 Vasodilating composition |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018821A1 Antifungal composition |
| 05/29/1997 | WO1997018820A1 External preparation for curing lesioned tissues |
| 05/29/1997 | WO1997018819A1 Antineoplastic methods and compositions employing optically pure (-)-fotemustine |
| 05/29/1997 | WO1997018818A1 Antineoplastic methods and compositions employing (+)-fotemustine |
| 05/29/1997 | WO1997018817A1 External preparation containing vitamin d or vitamin k |
| 05/29/1997 | WO1997018816A2 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 05/29/1997 | WO1997018815A2 The use of adenosine uptake inhibitors for treating retinal or optic nerve head damage |
| 05/29/1997 | WO1997018814A1 Pharmaceutical formulations |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | WO1997018812A1 Combination therapy for treating glaucoma |
| 05/29/1997 | WO1997018811A1 A method of treating myotonic dystrophy |
| 05/29/1997 | WO1997018810A1 A method and compositions for enhancing pregnancy success in an animal |
| 05/29/1997 | WO1997018809A1 Protein kinase c inhibitor |
| 05/29/1997 | WO1997018808A1 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus |
| 05/29/1997 | WO1997018807A1 Use of esuprone in the treatment of anxiety and anxiety-like states |
| 05/29/1997 | WO1997018806A1 Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
| 05/29/1997 | WO1997018805A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 05/29/1997 | WO1997018804A1 Rejuvenating the skin using a combination of vitamin a and alphahydroxy acids |
| 05/29/1997 | WO1997018803A1 The use of aliphatic carboxylic acid derivatives in ophthalmic disorders |
| 05/29/1997 | WO1997018802A1 Pharmaceutical compositions comprising flurbiprofen |
| 05/29/1997 | WO1997018801A1 Pharmaceutical formulation |
| 05/29/1997 | WO1997018800A1 Use of naphthoquinone compounds as antiprotozoal agents |
| 05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 05/29/1997 | WO1997018790A2 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | WO1997018782A1 Treatment with calcium channel blockers for drug-induced hypersensitivity |
| 05/29/1997 | WO1997018781A1 Method of treating nicotine dependence |
| 05/29/1997 | WO1997016155A3 Cosmetic and cosmeceutical compositions |
| 05/29/1997 | WO1997013774A3 Novel 5-o-deosaminyl 6-o-methyl erythronolide a derivatives, preparation method therefor and use thereof for preparing biologically active materials |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | WO1997013500A3 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 05/29/1997 | WO1997012582A3 Method for preventing and treating coccidiosis |
| 05/29/1997 | WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 05/29/1997 | CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2249343A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238310A1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/29/1997 | CA2238262A1 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2238048A1 Antifungal composition |
| 05/29/1997 | CA2238028A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 05/29/1997 | CA2238023A1 New quinoxalindione derivatives, their preparation and use in medicaments |
| 05/29/1997 | CA2237909A1 Antineoplastic methods and compositions employing (+)-fotemustine |
| 05/29/1997 | CA2237898A1 Combination therapy for treating glaucoma |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2237695A1 Antineoplastic methods and compositions employing optically pure (-)-fotemustine |
| 05/29/1997 | CA2237638A1 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/29/1997 | CA2237472A1 6-0-methyl erythromycin d and process for making |
| 05/29/1997 | CA2237016A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/29/1997 | CA2236834A1 Piperidine and tetrahydropyridine derivatives |
| 05/29/1997 | CA2236825A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2234240A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
| 05/29/1997 | CA2232715A1 Pharmaceutical formulations |
| 05/29/1997 | CA2232135A1 Solid mixtures of cyclodextrins prepared via melt-extrusion |
| 05/28/1997 | EP0775941A1 Radiation sensitive composition for color filters |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775704A1 Crystalline hydrochloride of (R)-(-)-2-[N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-butyl]-aminomethyl]-chroman |
| 05/28/1997 | EP0775698A1 Bis-resorcinol-triazines as UV absorber triazine |
| 05/28/1997 | EP0775692A1 Guanidinomethyl cyclohexane carboxylic ester derivative |
| 05/28/1997 | EP0775492A1 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in skin composition |
| 05/28/1997 | EP0775491A1 Immunopotentiator |
| 05/28/1997 | EP0775490A1 Immunopotentiator |
| 05/28/1997 | EP0775488A1 Stable pharmaceutical composition on the basis of acetylsalicyclic acid and tocopherol |
| 05/28/1997 | EP0775487A1 Triazine derivative and medicine |
| 05/28/1997 | EP0775486A1 Antibacterial, antimycotic and antviral compositions based on alpha-hydroxyalkanoic acids and squalene |
| 05/28/1997 | EP0775485A1 New dosage form of hydroxocobalamin and its use in cyanide poisoning |
| 05/28/1997 | EP0775484A1 Surfactant free aerosol formulations containing bezlomethsone dipropionate |
| 05/28/1997 | EP0775482A2 Cosmetic compositions containing tricholine citrate |
| 05/28/1997 | EP0775480A1 Novel lipidic furans useful for skin therapeutics |